Insmed Inc (INSM): Mistaken impressions.... No upfront p...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	0
Posts	139
Boards Moderated	0
Alias Born	01/08/2006

mpetisth1

Re: Aiming4 post# 4908

Sunday, 03/11/2007 1:14:20 PM

Sunday, March 11, 2007 1:14:20 PM

Mistaken impressions....

No upfront payment ? I bet we see one sooner than you think !

Option to review Phase II ("Phase III enabling") results before making an investment....I am sure that GENENTECH cleary understands the value and potential of iPLEX. They know what the clinical trials are proving. This settlement/partnership would not have taken place otherwise !

"On top of the above, unless I've missed it, Insmed wouldn't just have "free" access to DNA's sales force and marketing, that would be something Insmed "PRESUMABLY" would have to pay handsomely for."......I think you are dead WRONG !!!

If they do opt in,(I think they already have) their only financial obligation is 50% of the development costs...PAST - PRESENT - FUTURE for 50% of profit.... are you kidding ?....DEAL !!!

Market will SEE this partnership with GENENTECH INC as an enormous advantage for Insmed Inc.